Literature DB >> 27581290

In Vitro High-Throughput RNAi Screening to Accelerate the Process of Target Identification and Drug Development.

Hongwei Yin1, Michelle Kassner2.   

Abstract

High-throughput RNA interference (HT-RNAi) is a powerful tool that can be used to knock down gene expression in order to identify novel genes and pathways involved in many cellular processes. It is a systematic, yet unbiased, approach to identify essential or synthetic lethal genes that promote cell survival in diseased cells as well as genes that confer resistance or sensitivity to drug treatment. This information serves as a foundation for enhancing current treatments for cancer and other diseases by identifying new drug targets, uncovering potential combination therapies, and helping clinicians match patients with the most effective treatment based on genetic information. Here, we describe the method of performing an in vitro HT-RNAi screen using chemically synthesized siRNA.

Entities:  

Keywords:  Drug development; Drug sensitizer; Essential gene; Functional genomics; Gene knockdown; Gene silencing; High-throughput; RNA interference (RNAi); Synthetic lethal; Target discovery; siRNA

Mesh:

Substances:

Year:  2016        PMID: 27581290     DOI: 10.1007/978-1-4939-6337-9_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

Review 1.  Application and prospects of high-throughput screening for in vitro neurogenesis.

Authors:  Shu-Yuan Zhang; Juan Zhao; Jun-Jun Ni; Hui Li; Zhen-Zhen Quan; Hong Qing
Journal:  World J Stem Cells       Date:  2022-06-26       Impact factor: 5.247

Review 2.  Early Probe and Drug Discovery in Academia: A Minireview.

Authors:  Anuradha Roy
Journal:  High Throughput       Date:  2018-02-09

3.  Identification of PLK1 as a New Therapeutic Target in Mucinous Ovarian Carcinoma.

Authors:  Roberta Affatato; Laura Carrassa; Rosaria Chilà; Monica Lupi; Valentina Restelli; Giovanna Damia
Journal:  Cancers (Basel)       Date:  2020-03-13       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.